Allakos Inc. (ALLK) financial statements (2021 and earlier)

Company profile

Business Address 975 ISLAND DRIVE
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:659496179
Cash and cash equivalents2073834
Short-term investments452458145
Other undisclosed cash, cash equivalents, and short-term investments0(0)(0)
Other undisclosed current assets1043
Total current assets:669500182
Noncurrent Assets
Operating lease, right-of-use asset406
Property, plant and equipment889
Other noncurrent assets231
Total noncurrent assets:501710
TOTAL ASSETS:720517191
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22135
Accounts payable1462
Accrued liabilities873
Total current liabilities:22135
Noncurrent Liabilities
Long-term debt and lease obligation43  
Operating lease, liability43 
Liabilities, other than long-term debt 82
Other liabilities 82
Other undisclosed noncurrent liabilities(43)  
Total noncurrent liabilities:4382
Total liabilities:65217
Stockholders' equity
Stockholders' equity attributable to parent654496184
Common stock000
Additional paid in capital997685288
Accumulated other comprehensive income (loss)00(0)
Accumulated deficit(343)(189)(104)
Total stockholders' equity:654496184
TOTAL LIABILITIES AND EQUITY:720517191

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Operating expenses(157)(91)(46)
Operating loss:(157)(91)(46)
Nonoperating expense
(Other Nonoperating expense)
(1)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(158)(92)(46)
Other undisclosed income from continuing operations before income taxes 62
Loss before gain (loss) on sale of properties:(158)(85)(44)
Other undisclosed net income4  
Net loss available to common stockholders, diluted:(153)(85)(44)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(153)(85)(44)
Comprehensive loss:(153)(85)(44)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(154)(85)(44)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: